

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.61398916 |
| 2 | proteasome assembly (GO:0043248) | 5.16073786 |
| 3 | nuclear pore organization (GO:0006999) | 5.06759924 |
| 4 | formation of translation preinitiation complex (GO:0001731) | 4.98045976 |
| 5 | DNA replication checkpoint (GO:0000076) | 4.92229183 |
| 6 | diterpenoid biosynthetic process (GO:0016102) | 4.72432347 |
| 7 | regulation of translational fidelity (GO:0006450) | 4.67251090 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.56593959 |
| 9 | gas transport (GO:0015669) | 4.46368412 |
| 10 | terpenoid biosynthetic process (GO:0016114) | 4.40505984 |
| 11 | oxidative phosphorylation (GO:0006119) | 4.32445738 |
| 12 | oxygen transport (GO:0015671) | 4.23585963 |
| 13 | DNA replication initiation (GO:0006270) | 4.22644508 |
| 14 | synapsis (GO:0007129) | 4.20256270 |
| 15 | pore complex assembly (GO:0046931) | 4.17241664 |
| 16 | mitotic nuclear envelope disassembly (GO:0007077) | 4.15687908 |
| 17 | resolution of meiotic recombination intermediates (GO:0000712) | 4.13967606 |
| 18 | tRNA aminoacylation for protein translation (GO:0006418) | 4.13761485 |
| 19 | ribosome assembly (GO:0042255) | 4.06093349 |
| 20 | amino acid activation (GO:0043038) | 4.00679570 |
| 21 | tRNA aminoacylation (GO:0043039) | 4.00679570 |
| 22 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.95839779 |
| 23 | ATP synthesis coupled proton transport (GO:0015986) | 3.95839779 |
| 24 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.93183294 |
| 25 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.91577423 |
| 26 | rRNA methylation (GO:0031167) | 3.83077070 |
| 27 | DNA strand elongation (GO:0022616) | 3.81381693 |
| 28 | rRNA modification (GO:0000154) | 3.80982387 |
| 29 | purine nucleobase biosynthetic process (GO:0009113) | 3.80777487 |
| 30 | membrane disassembly (GO:0030397) | 3.77311603 |
| 31 | nuclear envelope disassembly (GO:0051081) | 3.77311603 |
| 32 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.69136199 |
| 33 | maturation of 5.8S rRNA (GO:0000460) | 3.68954868 |
| 34 | DNA unwinding involved in DNA replication (GO:0006268) | 3.64987808 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.61687282 |
| 36 | mitotic sister chromatid segregation (GO:0000070) | 3.61099109 |
| 37 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.60904890 |
| 38 | ribosome biogenesis (GO:0042254) | 3.60372751 |
| 39 | ribosomal large subunit biogenesis (GO:0042273) | 3.56648689 |
| 40 | nucleobase biosynthetic process (GO:0046112) | 3.52479880 |
| 41 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.50861473 |
| 42 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.47776480 |
| 43 | respiratory electron transport chain (GO:0022904) | 3.46483888 |
| 44 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.39329216 |
| 45 | IMP biosynthetic process (GO:0006188) | 3.37460031 |
| 46 | electron transport chain (GO:0022900) | 3.37365237 |
| 47 | aerobic respiration (GO:0009060) | 3.35782567 |
| 48 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.35279808 |
| 49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.34529053 |
| 50 | sister chromatid segregation (GO:0000819) | 3.30246696 |
| 51 | mitotic metaphase plate congression (GO:0007080) | 3.29352686 |
| 52 | pseudouridine synthesis (GO:0001522) | 3.26449885 |
| 53 | protein targeting to mitochondrion (GO:0006626) | 3.25524344 |
| 54 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.23782176 |
| 55 | positive regulation of ligase activity (GO:0051351) | 3.21109664 |
| 56 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.19688246 |
| 57 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.17649275 |
| 58 | mitotic recombination (GO:0006312) | 3.17524008 |
| 59 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.17321259 |
| 60 | telomere maintenance via recombination (GO:0000722) | 3.14011377 |
| 61 | oxaloacetate metabolic process (GO:0006107) | 3.11105384 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.09517330 |
| 63 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.09390791 |
| 64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.09216852 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.09040763 |
| 66 | regulation of translational elongation (GO:0006448) | 3.05382651 |
| 67 | chromosome segregation (GO:0007059) | 3.02944930 |
| 68 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00627720 |
| 69 | heme biosynthetic process (GO:0006783) | 3.00024744 |
| 70 | DNA topological change (GO:0006265) | 2.99407921 |
| 71 | regulation of mitotic spindle organization (GO:0060236) | 2.99089362 |
| 72 | cellular respiration (GO:0045333) | 2.98096768 |
| 73 | mitochondrial RNA metabolic process (GO:0000959) | 2.97181420 |
| 74 | negative regulation of ligase activity (GO:0051352) | 2.92861338 |
| 75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.92861338 |
| 76 | meiotic chromosome segregation (GO:0045132) | 2.90988592 |
| 77 | regulation of ligase activity (GO:0051340) | 2.90195732 |
| 78 | regulation of RNA export from nucleus (GO:0046831) | 2.90184218 |
| 79 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.89615242 |
| 80 | rRNA processing (GO:0006364) | 2.88392629 |
| 81 | transcription from mitochondrial promoter (GO:0006390) | 2.88375611 |
| 82 | IMP metabolic process (GO:0046040) | 2.88275623 |
| 83 | negative regulation of protein acetylation (GO:1901984) | 2.87774594 |
| 84 | nuclear envelope organization (GO:0006998) | 2.87512495 |
| 85 | establishment of protein localization to mitochondrion (GO:0072655) | 2.87504037 |
| 86 | protein-cofactor linkage (GO:0018065) | 2.86974352 |
| 87 | protein localization to mitochondrion (GO:0070585) | 2.86700024 |
| 88 | regulation of histone H3-K4 methylation (GO:0051569) | 2.85861737 |
| 89 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.84622595 |
| 90 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.83964938 |
| 91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.83964938 |
| 92 | maturation of SSU-rRNA (GO:0030490) | 2.83848368 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83714026 |
| 94 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.83166608 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.83166608 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.83166608 |
| 97 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.81980800 |
| 98 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.81980800 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.81044806 |
| 100 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.81044806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.72557751 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.46410974 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71072688 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59478040 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.52978440 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.36731876 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.31087193 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.27476078 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.19227188 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.16821402 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05428000 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.02178271 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84800835 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.77043493 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71959187 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63576386 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.59310615 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45541392 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.39823878 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.33472736 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.24833875 |
| 22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.21703226 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.19410660 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12731157 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05892860 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04227998 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02939812 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00316126 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98369643 |
| 30 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98084769 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.94533117 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.92308272 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88714800 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82690482 |
| 35 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81457737 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.80495616 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80017912 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.77036272 |
| 39 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.76492669 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.76171310 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74533865 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72264787 |
| 43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71518330 |
| 44 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.69262212 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66802005 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.65815060 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65427041 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65398147 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61707156 |
| 50 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.56230309 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54541176 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.53449705 |
| 53 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.53276699 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47582671 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44336280 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.42419984 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.33904269 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32779580 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30975983 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29357818 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26093623 |
| 62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25424452 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24255775 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23838052 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21932226 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16165762 |
| 67 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.14740610 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13360354 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12828509 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10784694 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07999988 |
| 72 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07082016 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06981409 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06136674 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04499379 |
| 76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04252712 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01060261 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98863505 |
| 79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98772673 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98279647 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97522474 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97048436 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94883501 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93518791 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93378694 |
| 86 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90420219 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90212163 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90156375 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89872504 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88759600 |
| 91 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87570407 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.87546754 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.86223585 |
| 94 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86133622 |
| 95 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.84559765 |
| 96 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.83740002 |
| 97 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83687852 |
| 98 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.80993139 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.79505572 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.77284375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 4.18024491 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.03972102 |
| 3 | MP0008058_abnormal_DNA_repair | 3.76720146 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.74126036 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.70741728 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.53222749 |
| 7 | MP0008995_early_reproductive_senescence | 3.38041601 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.37777393 |
| 9 | MP0005451_abnormal_body_composition | 3.20888064 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.95575384 |
| 11 | MP0003186_abnormal_redox_activity | 2.83994777 |
| 12 | MP0003786_premature_aging | 2.83726428 |
| 13 | MP0009697_abnormal_copulation | 2.83557826 |
| 14 | MP0003077_abnormal_cell_cycle | 2.72954303 |
| 15 | MP0005171_absent_coat_pigmentation | 2.62876461 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.58097513 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.40620903 |
| 18 | MP0005408_hypopigmentation | 2.38978384 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.36868892 |
| 20 | MP0003718_maternal_effect | 2.36440647 |
| 21 | MP0008057_abnormal_DNA_replication | 2.21190082 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.08130925 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 2.05625950 |
| 24 | MP0002132_abnormal_respiratory_system | 1.96611212 |
| 25 | MP0001881_abnormal_mammary_gland | 1.94459276 |
| 26 | MP0000678_abnormal_parathyroid_gland | 1.84952571 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.70904839 |
| 28 | MP0005083_abnormal_biliary_tract | 1.65783941 |
| 29 | MP0001730_embryonic_growth_arrest | 1.57953585 |
| 30 | MP0000350_abnormal_cell_proliferation | 1.55674168 |
| 31 | MP0001697_abnormal_embryo_size | 1.52850210 |
| 32 | MP0000358_abnormal_cell_content/ | 1.50907237 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.48932590 |
| 34 | MP0002210_abnormal_sex_determination | 1.48335473 |
| 35 | MP0001764_abnormal_homeostasis | 1.48135576 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.46073450 |
| 37 | MP0001929_abnormal_gametogenesis | 1.44788362 |
| 38 | MP0000313_abnormal_cell_death | 1.39719429 |
| 39 | MP0002080_prenatal_lethality | 1.35040625 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.33182926 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.32395781 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.32395781 |
| 43 | MP0003959_abnormal_lean_body | 1.29839179 |
| 44 | MP0001661_extended_life_span | 1.28555558 |
| 45 | MP0001672_abnormal_embryogenesis/_devel | 1.26423727 |
| 46 | MP0005380_embryogenesis_phenotype | 1.26423727 |
| 47 | MP0004484_altered_response_of | 1.24767167 |
| 48 | MP0005410_abnormal_fertilization | 1.16936159 |
| 49 | MP0003984_embryonic_growth_retardation | 1.15484455 |
| 50 | MP0002088_abnormal_embryonic_growth/wei | 1.11727535 |
| 51 | MP0004233_abnormal_muscle_weight | 1.10887294 |
| 52 | MP0002086_abnormal_extraembryonic_tissu | 1.06253805 |
| 53 | MP0003698_abnormal_male_reproductive | 1.03540234 |
| 54 | MP0001145_abnormal_male_reproductive | 1.02581673 |
| 55 | MP0002095_abnormal_skin_pigmentation | 1.00392072 |
| 56 | MP0000653_abnormal_sex_gland | 0.99510189 |
| 57 | MP0005330_cardiomyopathy | 0.98182516 |
| 58 | MP0006138_congestive_heart_failure | 0.97684739 |
| 59 | MP0008961_abnormal_basal_metabolism | 0.94289223 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 0.93283509 |
| 61 | MP0010307_abnormal_tumor_latency | 0.90343355 |
| 62 | MP0003646_muscle_fatigue | 0.89815482 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 0.85296026 |
| 64 | MP0001727_abnormal_embryo_implantation | 0.84611057 |
| 65 | MP0002396_abnormal_hematopoietic_system | 0.83465017 |
| 66 | MP0000015_abnormal_ear_pigmentation | 0.83214840 |
| 67 | MP0002161_abnormal_fertility/fecundity | 0.79390488 |
| 68 | MP0002085_abnormal_embryonic_tissue | 0.79317624 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.79206598 |
| 70 | MP0003699_abnormal_female_reproductive | 0.77916174 |
| 71 | MP0005266_abnormal_metabolism | 0.76901766 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76177353 |
| 73 | MP0005332_abnormal_amino_acid | 0.75706405 |
| 74 | MP0001502_abnormal_circadian_rhythm | 0.75702249 |
| 75 | MP0008770_decreased_survivor_rate | 0.73996599 |
| 76 | MP0003936_abnormal_reproductive_system | 0.73721608 |
| 77 | MP0002084_abnormal_developmental_patter | 0.71924826 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.71593103 |
| 79 | MP0001119_abnormal_female_reproductive | 0.70285271 |
| 80 | MP0001919_abnormal_reproductive_system | 0.70126565 |
| 81 | MP0004272_abnormal_basement_membrane | 0.70038519 |
| 82 | MP0002160_abnormal_reproductive_system | 0.69195396 |
| 83 | MP0000609_abnormal_liver_physiology | 0.67996084 |
| 84 | MP0000647_abnormal_sebaceous_gland | 0.67707972 |
| 85 | MP0008260_abnormal_autophagy | 0.66512803 |
| 86 | MP0002938_white_spotting | 0.64958353 |
| 87 | MP0003828_pulmonary_edema | 0.64024859 |
| 88 | MP0001915_intracranial_hemorrhage | 0.63784699 |
| 89 | MP0005389_reproductive_system_phenotype | 0.62880362 |
| 90 | MP0005384_cellular_phenotype | 0.62573152 |
| 91 | MP0000598_abnormal_liver_morphology | 0.62429228 |
| 92 | MP0005360_urolithiasis | 0.62359248 |
| 93 | MP0002269_muscular_atrophy | 0.61364643 |
| 94 | MP0000747_muscle_weakness | 0.61118680 |
| 95 | MP0003136_yellow_coat_color | 0.60951161 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.60663902 |
| 97 | MP0005395_other_phenotype | 0.60590854 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.59190506 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.58763292 |
| 100 | MP0004381_abnormal_hair_follicle | 0.58373823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cholecystitis (HP:0001082) | 5.95271176 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 5.95271176 |
| 3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.83807104 |
| 4 | Abnormal hemoglobin (HP:0011902) | 4.37302437 |
| 5 | Truncus arteriosus (HP:0001660) | 4.35682197 |
| 6 | Hyperthyroidism (HP:0000836) | 4.11483168 |
| 7 | Reticulocytosis (HP:0001923) | 4.10816967 |
| 8 | Acute encephalopathy (HP:0006846) | 4.03891463 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.03645168 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.98505186 |
| 11 | Chromsome breakage (HP:0040012) | 3.91975188 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.91132562 |
| 13 | Abnormality of reticulocytes (HP:0004312) | 3.83480559 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.72418559 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.67024964 |
| 16 | Abnormality of glycolysis (HP:0004366) | 3.65118679 |
| 17 | Ileus (HP:0002595) | 3.63736490 |
| 18 | Upper limb muscle weakness (HP:0003484) | 3.42244370 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.35156246 |
| 20 | Increased CSF lactate (HP:0002490) | 3.30713437 |
| 21 | Seborrheic dermatitis (HP:0001051) | 3.26362979 |
| 22 | Reticulocytopenia (HP:0001896) | 3.25770363 |
| 23 | Progressive macrocephaly (HP:0004481) | 3.17341412 |
| 24 | Hypertensive crisis (HP:0100735) | 3.15834121 |
| 25 | Pallor (HP:0000980) | 3.14996137 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.04369970 |
| 27 | Abnormality of the preputium (HP:0100587) | 2.99022566 |
| 28 | Abnormality of the tricuspid valve (HP:0001702) | 2.98060321 |
| 29 | Polycythemia (HP:0001901) | 2.92238746 |
| 30 | Hepatocellular necrosis (HP:0001404) | 2.82170838 |
| 31 | Cholelithiasis (HP:0001081) | 2.79116714 |
| 32 | Duplicated collecting system (HP:0000081) | 2.75282078 |
| 33 | Spastic paraparesis (HP:0002313) | 2.70274446 |
| 34 | Hypoparathyroidism (HP:0000829) | 2.69938175 |
| 35 | Tinnitus (HP:0000360) | 2.68183810 |
| 36 | Cerebral edema (HP:0002181) | 2.66783908 |
| 37 | Abnormality of homocysteine metabolism (HP:0010919) | 2.65154887 |
| 38 | Homocystinuria (HP:0002156) | 2.65154887 |
| 39 | Increased hepatocellular lipid droplets (HP:0006565) | 2.62446038 |
| 40 | CNS hypomyelination (HP:0003429) | 2.61869293 |
| 41 | Increased serum lactate (HP:0002151) | 2.57609065 |
| 42 | Short middle phalanx of the 5th finger (HP:0004220) | 2.52643001 |
| 43 | Abnormal large intestine physiology (HP:0012700) | 2.52482322 |
| 44 | Bowel incontinence (HP:0002607) | 2.51923438 |
| 45 | Abnormality of cochlea (HP:0000375) | 2.46402329 |
| 46 | Hepatic necrosis (HP:0002605) | 2.46177605 |
| 47 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.45340854 |
| 48 | Poikilocytosis (HP:0004447) | 2.43097046 |
| 49 | Abnormal gallbladder morphology (HP:0012437) | 2.42213013 |
| 50 | Abnormality of the renal collecting system (HP:0004742) | 2.41578058 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 2.39563891 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.37446077 |
| 53 | Ureteral duplication (HP:0000073) | 2.36972291 |
| 54 | Lactic acidosis (HP:0003128) | 2.32706556 |
| 55 | Ankyloglossia (HP:0010296) | 2.30465925 |
| 56 | Respiratory difficulties (HP:0002880) | 2.30209000 |
| 57 | Morphological abnormality of the inner ear (HP:0011390) | 2.25579024 |
| 58 | Meckel diverticulum (HP:0002245) | 2.22318410 |
| 59 | Cortical dysplasia (HP:0002539) | 2.21191476 |
| 60 | Myelodysplasia (HP:0002863) | 2.19700738 |
| 61 | Abnormality of chromosome stability (HP:0003220) | 2.19480815 |
| 62 | Abnormality of DNA repair (HP:0003254) | 2.19223780 |
| 63 | Atelectasis (HP:0100750) | 2.18519686 |
| 64 | Microvesicular hepatic steatosis (HP:0001414) | 2.17304842 |
| 65 | Pheochromocytoma (HP:0002666) | 2.16755211 |
| 66 | Small intestinal stenosis (HP:0012848) | 2.15207994 |
| 67 | Duodenal stenosis (HP:0100867) | 2.15207994 |
| 68 | Premature ovarian failure (HP:0008209) | 2.14554587 |
| 69 | Secondary amenorrhea (HP:0000869) | 2.12028024 |
| 70 | Respiratory failure (HP:0002878) | 2.10771723 |
| 71 | Redundant skin (HP:0001582) | 2.08800845 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.08617955 |
| 73 | Abnormality of the ileum (HP:0001549) | 2.07605781 |
| 74 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.04542525 |
| 75 | Leukodystrophy (HP:0002415) | 2.04220644 |
| 76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03581782 |
| 77 | Delusions (HP:0000746) | 2.02624723 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.01668403 |
| 79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98658817 |
| 80 | Hypoplasia of the fovea (HP:0007750) | 1.98658817 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 1.95997280 |
| 82 | CNS demyelination (HP:0007305) | 1.93891187 |
| 83 | Abnormality of the gallbladder (HP:0005264) | 1.93807448 |
| 84 | Emotional lability (HP:0000712) | 1.93709876 |
| 85 | Hyperbilirubinemia (HP:0002904) | 1.92989717 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92740798 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91883390 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 1.91883390 |
| 89 | Hyperalaninemia (HP:0003348) | 1.91883390 |
| 90 | Exercise intolerance (HP:0003546) | 1.91063168 |
| 91 | Abnormally folded helix (HP:0008544) | 1.87123944 |
| 92 | Macrocytic anemia (HP:0001972) | 1.86771321 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 1.83082237 |
| 94 | Breech presentation (HP:0001623) | 1.82699918 |
| 95 | Adenoma sebaceum (HP:0009720) | 1.81757056 |
| 96 | Angiofibromas (HP:0010615) | 1.81757056 |
| 97 | Abnormality of the carotid arteries (HP:0005344) | 1.80907047 |
| 98 | Conjunctival hamartoma (HP:0100780) | 1.80795793 |
| 99 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80122298 |
| 100 | Abnormality of methionine metabolism (HP:0010901) | 1.79974632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 5.06081156 |
| 2 | SIK3 | 4.80131823 |
| 3 | EIF2AK1 | 4.34012284 |
| 4 | PBK | 3.54544068 |
| 5 | NEK1 | 3.35327792 |
| 6 | MAP3K3 | 3.23357363 |
| 7 | TTK | 2.71144775 |
| 8 | KSR1 | 2.67119738 |
| 9 | EIF2AK3 | 2.60263525 |
| 10 | PDK2 | 2.48663205 |
| 11 | CCNB1 | 2.37207947 |
| 12 | BCR | 2.34603461 |
| 13 | BUB1 | 2.29548562 |
| 14 | MST4 | 2.20256527 |
| 15 | SRPK1 | 2.10167283 |
| 16 | CDC7 | 2.04418966 |
| 17 | RIPK4 | 1.97506651 |
| 18 | CLK1 | 1.91406574 |
| 19 | KSR2 | 1.90056536 |
| 20 | NME1 | 1.89996262 |
| 21 | STK16 | 1.89151616 |
| 22 | NME2 | 1.84985719 |
| 23 | PLK4 | 1.75973923 |
| 24 | WEE1 | 1.69880193 |
| 25 | TSSK6 | 1.66689844 |
| 26 | BRSK2 | 1.65169179 |
| 27 | RAF1 | 1.57828283 |
| 28 | BRSK1 | 1.35450002 |
| 29 | BMPR2 | 1.31102340 |
| 30 | NTRK3 | 1.27325442 |
| 31 | CHEK2 | 1.21470059 |
| 32 | IRAK3 | 1.14831483 |
| 33 | MAP3K2 | 1.14516772 |
| 34 | PLK3 | 1.09389309 |
| 35 | MAP3K8 | 1.08683183 |
| 36 | NEK2 | 1.08483189 |
| 37 | WNK4 | 1.06782728 |
| 38 | SCYL2 | 0.95353074 |
| 39 | STK4 | 0.92583426 |
| 40 | PLK1 | 0.91396996 |
| 41 | ALK | 0.90023051 |
| 42 | ATR | 0.86978189 |
| 43 | MKNK1 | 0.84878324 |
| 44 | EEF2K | 0.83299107 |
| 45 | ILK | 0.82730606 |
| 46 | STK3 | 0.80369139 |
| 47 | CHEK1 | 0.80178594 |
| 48 | TAOK3 | 0.79133213 |
| 49 | PIK3CG | 0.78023935 |
| 50 | BRAF | 0.77998134 |
| 51 | RPS6KB2 | 0.77426497 |
| 52 | AKT3 | 0.76177847 |
| 53 | ICK | 0.72956954 |
| 54 | BMX | 0.70566907 |
| 55 | AURKB | 0.66469094 |
| 56 | PAK1 | 0.64337351 |
| 57 | EIF2AK2 | 0.63912979 |
| 58 | MINK1 | 0.63195840 |
| 59 | MARK3 | 0.59152304 |
| 60 | CDK2 | 0.55233999 |
| 61 | CDK1 | 0.54412973 |
| 62 | ATM | 0.52807005 |
| 63 | CSNK2A2 | 0.52558239 |
| 64 | CDK18 | 0.49825769 |
| 65 | ZAK | 0.48309305 |
| 66 | CSNK2A1 | 0.45586963 |
| 67 | VRK2 | 0.44292767 |
| 68 | NUAK1 | 0.41311274 |
| 69 | CSNK1E | 0.41211020 |
| 70 | MAPKAPK5 | 0.40888015 |
| 71 | MKNK2 | 0.40417925 |
| 72 | MAPKAPK2 | 0.39264184 |
| 73 | CDK7 | 0.38995897 |
| 74 | TRPM7 | 0.38757208 |
| 75 | STK10 | 0.37851226 |
| 76 | MAPKAPK3 | 0.37570800 |
| 77 | PIM1 | 0.37463766 |
| 78 | AURKA | 0.35958710 |
| 79 | DMPK | 0.34086476 |
| 80 | PAK4 | 0.33488221 |
| 81 | MAP3K12 | 0.32924480 |
| 82 | DYRK1A | 0.32212921 |
| 83 | MAP2K1 | 0.30154117 |
| 84 | CDK11A | 0.27192589 |
| 85 | RPS6KA5 | 0.26849828 |
| 86 | JAK2 | 0.26825520 |
| 87 | PLK2 | 0.26264042 |
| 88 | TEC | 0.25020610 |
| 89 | CDK15 | 0.22353381 |
| 90 | CDK14 | 0.21683565 |
| 91 | MAPK4 | 0.21049670 |
| 92 | AKT2 | 0.20836183 |
| 93 | MAPK14 | 0.19913598 |
| 94 | PRKCI | 0.18785452 |
| 95 | GSK3A | 0.18576757 |
| 96 | ERBB3 | 0.17513181 |
| 97 | GSK3B | 0.17316985 |
| 98 | LRRK2 | 0.16903606 |
| 99 | JAK3 | 0.16834802 |
| 100 | MAP3K1 | 0.15807285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.98656056 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.61041196 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.43610608 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.39719461 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.17536970 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.04143122 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.94863646 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.83131957 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.77444375 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.69110304 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.66298714 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.53397717 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.45671014 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 2.26643481 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.15880094 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.02087522 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.98120771 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.95773984 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.85657298 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.81858578 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.74276294 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.69326881 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.68977499 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67131440 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62245859 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.60967720 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.59675849 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.56976308 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48440172 |
| 30 | RNA degradation_Homo sapiens_hsa03018 | 1.41116075 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40100359 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38519425 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37150508 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36581623 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32795284 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28912634 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28423112 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21836025 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.21241657 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18023591 |
| 41 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.16078074 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08689548 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03549866 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99245745 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98095266 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97992907 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96287176 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89612075 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84770589 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83987922 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81540024 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77252214 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76883878 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73885482 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73196527 |
| 56 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71081562 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66289120 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63985673 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62980622 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61409757 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60201414 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59916381 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58399877 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50455518 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49821341 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47284997 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46325824 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45214267 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44509835 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43838351 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43412342 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36901055 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33582542 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26031991 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25651035 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25554172 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25436712 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24033444 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23137931 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23008250 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22897674 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22523584 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.21607162 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17160093 |
| 85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.15273110 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.14622209 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13524937 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.12830191 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.11982517 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.11263512 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08585776 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.06518374 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05970999 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.04480398 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03700508 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.03618339 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.02782207 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.02172998 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.02105631 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0030001 |

